Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,559.90
+39.90 (1.13%)
Sep 11, 2026, 3:29 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 441.45 billion as of September 11, 2026. Its market cap has increased by 36.28% in one year.
Market Cap
441.45B
Enterprise Value
437.48B
Revenue
57.76B
Ranking
n/a
PE Ratio
38.91
Stock Price
3,559.90
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 441.45B, an increase of 77,922.43%. That is a compound annual growth rate of 31.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 441.45B | 27.66% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.05T |
| Aurobindo Pharma | 977.51B |
| Mankind Pharma | 924.45B |
| Glenmark Pharmaceuticals | 681.51B |
| Alkem Laboratories | 614.44B |
| Gland Pharma | 499.22B |
| Ipca Laboratories | 498.17B |
| Emcure Pharmaceuticals | 372.30B |